Literature DB >> 10568892

A conceptual framework for clinical trials in SLE and other multisystem diseases.

M H Liang1, M Corzillius, S C Bae, P Fortin, J M Esdaile, M Abrahamowicz.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10568892     DOI： 10.1191/096120399680411290

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  3 in total

1.  Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.

Authors:  L Barile-Fabris; R Ariza-Andraca; L Olguín-Ortega; L J Jara; A Fraga-Mouret; J M Miranda-Limón; J Fuentes de la Mata; P Clark; F Vargas; J Alocer-Varela
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

Review 2.  Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.

Authors:  Kristin M Corapi; Mary Anne Dooley; William F Pendergraft
Journal:  Arthritis Res Ther       Date:  2015-04-28       Impact factor: 5.156

3.  External Validation of the Lupus Multivariable Outcome Score for Systemic Lupus Erythematosus Trials.

Authors:  Michal Abrahamowicz; Maria Izabela Abrahamowicz; Peter E Lipsky
Journal:  ACR Open Rheumatol       Date:  2022-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.